The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer risk​The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer risk 

The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. Moderate caffeine intake linked to significantly lower dementia risk Recent longitudinal data suggests that your morning coffee or tea might be doing more than just waking you up. A massive study involving over 400,000 participants Read More

Blockbuster weight loss drugs like Ozempic deliver big results but face big questions​Blockbuster weight loss drugs like Ozempic deliver big results but face big questions 

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long Read More

Ozempic Pill Launching; Glucose Monitor Makers Warned; Thyroidectomy in Older Adults​Ozempic Pill Launching; Glucose Monitor Makers Warned; Thyroidectomy in Older Adults 

(MedPage Today) — The FDA approved three doses — 1.5 mg, 4 mg, and 9 mg — of a new oral semaglutide formulation for diabetes (Ozempic tablets), Novo Nordisk announced. An ad for Novo Nordisk’s weight loss pill version of semaglutide (Wegovy… ​ (MedPage Today) — The FDA approved three doses — 1.5 mg, 4 Read More